XML 137 R38.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Summary of Significant Accounting Policies (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2024 | Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |
Schedule of Property and Equipment | Schedule of Property and Equipment
|  | (in thousands) |
|  | September 30, 2024 |  |  | December 31, 2023 |
Furniture, fixtures, and equipment |  |  | 1,466 |  |  |  | 1,448 |
Less: accumulated depreciation |  |  | (1,349 | ) |  |  | (1,321 | )
Property and equipment, net |  | $ | 117 |  |  | $ | 127 |
| Schedule of Property and Equipment
|  | 2023 |  |  | 2022 |
|  | (in thousands) December 31, |
|  | 2023 |  |  | 2022 |
Furniture, fixture and equipment |  | $ | 1,448 |  |  | $ | 2,233 |
Less: accumulated depreciation |  |  | (1,321 | ) |  |  | (2,038 | )
Property and equipment, net |  | $ | 127 |  |  | $ | 195 |
Schedule of Available of Sale |  | Mutual Funds classified as available for sale consisted of: (in thousands) December 31, 2023 Schedule of Available of Sale
Securities |  | Fair Value |  |  | Short-Term Investments |
Mutual Funds |  | $ | 7,631 |  |  | $ | 7,631 |
Totals |  | $ | 7,631 |  |  | $ | 7,631 |
Mutual Funds classified as available for sale consisted of: (in thousands) December 31, 2022
Securities |  | Fair Value |  |  | Short-Term Investments |
Mutual Funds |  | $ | 7,137 |  |  | $ | 7,137 |
Totals |  | $ | 7,137 |  |  | $ | 7,137 |
Schedule of Equity Securities |  | Schedule of Equity Securities
Securities |  |  |
Net gain recognized during the year on equity securities |  | $ | 200 |
Less: Net gains and losses recognized during the year on equity securities sold during the year |  |  | (176 | )
Unrealized gains and losses recognized during the year on equity securities still held at the end of the year |  | $ | 376 |
(in thousands) December 31, 2022
Securities |  |  |
Net losses recognized during the period on equity securities |  | $ | (1,679 | )
Less: Net gains and losses recognized during the period on equity securities sold during the year |  |  | (751 | )
Unrealized gains and losses recognized during the reporting period on equity securities still held at the end of the year |  | $ | (928 | )
Schedule of Options and Equity Estimated Based on Weighted Average Assumptions |  | Schedule of Options and Equity Estimated Based on Weighted Average Assumptions
|  | Year Ended December 31, |
|  | 2023 |  |  | 2022 |
Risk-free interest rate |  |  | 4.37 | % |  |  | 1.74% - 3.88% |
Expected dividend yield |  |  | — |  |  |  | — |
Expected life |  |  | 10 years |  |  |  | 10 years |
Expected volatility |  |  | 99.91 | % |  |  | 98.43% - 107.18% |
Weighted average grant date fair value for options issued |  |  | $0.43 per option for 400,000 options |  |  |  | $0.51 per option for 850,000 options |
Schedule of Warrants Outstanding and Exercisable |  | Information regarding warrants outstanding and exercisable into shares of common stock is summarized below: Schedule of Warrants Outstanding and Exercisable
|  | 2023 |  |  | 2022 |
|  |  |  |  | Warrant |  |  | Weighted Average Exercise |  |  |  |  |  | Warrant |  |  | Weighted Average Exercise |
|  | Shares |  |  | Price |  |  | Price |  |  | Shares |  |  | Price |  |  | Price |
Outstanding, beginning of year |  |  | 226,610 |  |  |  | $ 0.99-132.00 |  |  | $ | 9.10 |  |  |  | 294,939 |  |  |  | $0.99 – 469.92 |  |  | $ | 15.19 |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Expired |  |  | (74,450 | ) |  |  | 17.05 |  |  |  | 17.05 |  |  |  | (68,215 | ) |  |  | 469.92 |  |  |  | 469.92 |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (114 | ) |  |  | 8.80 |  |  |  | 8.80 |
Outstanding, end of year |  |  | 152,160 |  |  |  | $ 0.99-8.80 |  |  | $ | 8.03 |  |  |  | 226,610 |  |  |  | $ 0.99-132.00 |  |  | $ | 9.10 |
Exercisable |  |  | 152,160 |  |  |  | $ 0.99-8.80 |  |  | $ | 8.03 |  |  |  | 226,610 |  |  |  | $ 0.99-132.00 |  |  | $ | 9.10 |
Weighted average remaining contractual life |  |  | .75 years |  |  |  |  |  |  |  |  |  |  |  | .94 years |  |  |  |  |  |  |  |  |
Years exercisable |  |  | 2024 |  |  |  |  |  |  |  |  |  |  |  | 2023-2024 |  |  |  |  |  |  |  |  |
Share-Based Payment Arrangement, Employee [Member] |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |
Schedule of Vest Stock Option Activity | Stock option activity for employees: Schedule of Stock Option Activity
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding June 30, 2024 |  |  | 2,407,775 |  |  | $ | 2.50 |  |  |  | 8.70 |  |  | $ | — |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeited |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Expired |  |  | (95 | ) |  |  | — |  |  |  | — |  |  |  | — |
Outstanding September 30, 2024 |  |  | 2,407,680 |  |  | $ | 2.44 |  |  |  | 8.70 |  |  | $ | — |
Vested and expected to vest September 30, 2024 |  |  | 2,407,680 |  |  | $ | 2.44 |  |  |  | 8.70 |  |  | $ | — |
Exercisable September 30, 2024 |  |  | 2,341,014 |  |  | $ | 1.66 |  |  |  | 7.17 |  |  | $ | — |
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding January 1, 2024 |  |  | 2,408,438 |  |  | $ | 2.50 |  |  |  | 8.70 |  |  | $ | — |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeited |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Expired |  |  | (758 | ) |  |  | — |  |  |  | — |  |  |  | — |
Outstanding September 30, 2024 |  |  | 2,407,680 |  |  | $ | 2.44 |  |  |  | 8.70 |  |  | $ | — |
Vested and expected to vest September 30, 2024 |  |  | 2,407,680 |  |  | $ | 2.44 |  |  |  | 8.70 |  |  | $ | — |
Exercisable September 30, 2024 |  |  | 2,341,014 |  |  | $ | 1.66 |  |  |  | 7.17 |  |  | $ | — |
| Vested stock option activity for employees: Schedule of Vest Stock Option Activity
|  | Number of |  |  | Weighted Average Exercise |  |  | Weighted Average Remaining Contracted Term |  |  | Aggregate Intrinsic |
|  | Options |  |  | Price |  |  | (Years) |  |  | Value |
Outstanding December 31, 2021 |  |  | 1,498,798 |  |  | $ | 4.22 |  |  |  | 9.11 |  |  |  | — |
Granted |  |  | 550,000 |  |  |  | 0.49 |  |  |  | 9.71 |  |  |  | — |
Forfeited |  |  | (28,584 | ) |  |  | 17.71 |  |  |  | — |  |  |  | — |
Expired |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Outstanding December 31, 2022 |  |  | 2,020,214 |  |  | $ | 3.01 |  |  |  | 8.86 |  |  |  | — |
Granted |  |  | 400,000 |  |  |  | 0.47 |  |  |  | 10.17 |  |  |  | — |
Forfeited |  |  | (7,601 | ) |  |  | 9.68 |  |  |  | — |  |  |  |  |
Expired |  |  | (4,175 | ) |  |  | 41.61 |  |  |  | — |  |  |  | — |
Outstanding December 31, 2023 |  |  | 2,408,438 |  |  | $ | 2.50 |  |  |  | 8.70 |  |  |  | — |
Vested and expected to vest at December 31, 2023 |  |  | 2,041,772 |  |  | $ | 1.90 |  |  |  | 6.73 |  |  |  | — |
Exercisable at December 31, 2023 |  |  | 2,041,772 |  |  | $ | 1.90 |  |  |  | 6.73 |  |  |  | — |
Schedule of Unvested Stock Option Activity | Unvested stock option activity for employees: Schedule of Unvested Stock Option Activity
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Unvested June 30, 2024 |  |  | 166,666 |  |  | $ | 4.11 |  |  |  | 18.87 |  |  | $ | — |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Expired |  |  | (95 | ) |  |  | — |  |  |  | — |  |  |  | — |
Vested |  |  | (99,905 | ) |  |  | 0.47 |  |  |  | 7.17 |  |  |  | — |
Unvested September 30, 2024 |  |  | 66,666 |  |  | $ | 9.61 |  |  |  | 36.22 |  |  | $ | — |
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Unvested January 1, 2024 |  |  | 366,666 |  |  | $ | 2.13 |  |  |  | 12.44 |  |  | $ | — |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Expired |  |  | (758 | ) |  |  | — |  |  |  | — |  |  |  | — |
Vested |  |  | (299,242 | ) |  |  | 0.47 |  |  |  | 7.17 |  |  |  | — |
Unvested September 30, 2024 |  |  | 66,666 |  |  | $ | 9.61 |  |  |  | 36.22 |  |  | $ | — |
| Unvested stock option activity for employees: Schedule of Unvested Stock Option Activity
|  | Number of |  |  | Weighted Average Exercise |  |  | Average Remaining Contracted Term |  |  | Aggregate Intrinsic |
|  | Options |  |  | Price |  |  | (Years) |  |  | Value |
Unvested December 31, 2021 |  |  | 412,500 |  |  | $ | 4.15 |  |  |  | 5.85 |  |  |  | — |
Granted |  |  | 550,000 |  |  |  | 0.49 |  |  |  | 9.71 |  |  |  | — |
Vested |  |  | (541,590 | ) |  |  | 1.31 |  |  |  | 9.73 |  |  |  | — |
Forfeited |  |  | (28,584 | ) |  |  | 17.71 |  |  |  | — |  |  |  | — |
Unvested December 31, 2022 |  |  | 392,326 |  |  | $ | 0.80 |  |  |  | 8.86 |  |  |  | — |
Granted |  |  | 400,000 |  |  |  | 0.47 |  |  |  | 10.17 |  |  |  | — |
Vested |  |  | (413,884 | ) |  |  | 1.90 |  |  |  | 6.73 |  |  |  | — |
Forfeited |  |  | (7,601 | ) |  |  | 9.68 |  |  |  | — |  |  |  | — |
Expired |  |  | (4,175 | ) |  |  | 41.61 |  |  |  | — |  |  |  | — |
Unvested December 31, 2023 |  |  | 366,666 |  |  | $ | 2.13 |  |  |  | 12.44 |  |  |  | — |
Share-Based Payment Arrangement, Nonemployee [Member] |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |
Schedule of Vest Stock Option Activity | Stock option activity for non-employees: Schedule of Stock Option Activity
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding June 30, 2024 |  |  | 885,055 |  |  | $ | 2.02 |  |  |  | 9.23 |  |  | $ | — |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeited |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Expired |  |  | (95 | ) |  |  | — |  |  |  | — |  |  |  | — |
Outstanding September 30, 2024 |  |  | 884,960 |  |  | $ | 1.88 |  |  |  | 9.23 |  |  | $ | — |
Vested and expected to vest September 30, 2024 |  |  | 884,960 |  |  | $ | 1.88 |  |  |  | 9.23 |  |  | $ | — |
Exercisable September 30, 2024 |  |  | 729,960 |  |  | $ | 1.87 |  |  |  | 10.06 |  |  | $ | — |
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding January 1, 2024 |  |  | 885,055 |  |  | $ | 2.02 |  |  |  | 9.23 |  |  | $ | — |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeited |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Expired |  |  | (95 | ) |  |  | — |  |  |  | — |  |  |  | — |
Outstanding September 30, 2024 |  |  | 884,960 |  |  | $ | 1.88 |  |  |  | 9.23 |  |  | $ | — |
Vested and expected to vest September 30, 2024 |  |  | 884,960 |  |  | $ | 1.88 |  |  |  | 9.23 |  |  | $ | — |
Exercisable September 30, 2024 |  |  | 729,960 |  |  | $ | 1.87 |  |  |  | 10.06 |  |  | $ | — |
| Vested stock option activity for non-employees: Schedule of Vest Stock Option Activity
|  | Number of |  |  | Weighted Average Exercise |  |  | Weighted Average Remaining Contracted Term |  |  | Aggregate Intrinsic |
|  | Options |  |  | Price |  |  | (Years) |  |  | Value |
Outstanding December 31, 2021 |  |  | 279,723 |  |  | $ | 6.12 |  |  |  | 7.93 |  |  |  | — |
Granted |  |  | 300,000 |  |  |  | 0.54 |  |  |  | 9.68 |  |  |  | — |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeited |  |  | (568 | ) |  |  | 153.12 |  |  |  | — |  |  |  | — |
Outstanding December 31, 2022 |  |  | 579,155 |  |  | $ | 3.09 |  |  |  | 8.36 |  |  |  | — |
Granted |  |  | 360,000 |  |  |  | 0.46 |  |  |  | 10.04 |  |  |  | — |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Expired |  |  | (653 | ) |  |  | 145.24 |  |  |  | — |  |  |  | — |
Forfeited |  |  | (53,447 | ) |  |  | 1.31 |  |  |  | — |  |  |  | — |
Outstanding December 31, 2023 |  |  | 885,055 |  |  | $ | 2.02 |  |  |  | 9.23 |  |  |  | — |
Vested and expected to vest at December 31, 2023 |  |  | 550,055 |  |  | $ | 2.56 |  |  |  | 10.02 |  |  |  | — |
Exercisable at December 31, 2023 |  |  | 550,055 |  |  | $ | 2.56 |  |  |  | 10.02 |  |  |  | — |
Schedule of Unvested Stock Option Activity | Unvested stock option activity for non-employees: Schedule of Unvested Stock Option Activity
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Unvested June 30, 2024 |  |  | 155,001 |  |  | $ | 3.42 |  |  |  | 11.30 |  |  | $ | — |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Expired |  |  | (95 | ) |  |  | — |  |  |  | — |  |  |  | — |
Vested |  |  | 95 |  |  |  | 0.46 |  |  |  | 10.18 |  |  |  | — |
Unvested September 30, 2024 |  |  | 155,001 |  |  | $ | 3.42 |  |  |  | 11.31 |  |  | $ | — |
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Unvested January 1, 2024 |  |  | 335,001 |  |  | $ | 1.83 |  |  |  | 10.70 |  |  | $ | — |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Expired |  |  | (95 | ) |  |  | — |  |  |  | — |  |  |  | — |
Vested |  |  | (179,905 | ) |  |  | 0.46 |  |  |  | 10.18 |  |  |  | — |
Unvested September 30, 2024 |  |  | 155,001 |  |  | $ | 3.42 |  |  |  | 11.31 |  |  | $ | — |
| Unvested stock option activity for non-employees: Schedule of Unvested Stock Option Activity
|  | Number of |  |  | Weighted Average Exercise |  |  | Weighted Average Remaining Contracted Term |  |  | Aggregate Intrinsic |
|  | Options |  |  | Price |  |  | (Years) |  |  | Value |
Unvested December 31, 2021 |  |  | 97,831 |  |  | $ | 3.89 |  |  |  | 7.82 |  |  |  | — |
Granted |  |  | 300,000 |  |  |  | 0.54 |  |  |  | 9.68 |  |  |  | — |
Vested |  |  | (229,053 | ) |  |  | 0.82 |  |  |  | — |  |  |  | — |
Forfeited |  |  | (1,989 | ) |  |  | — |  |  |  | — |  |  |  | — |
Unvested December 31, 2022 |  |  | 166,789 |  |  | $ | 4.05 |  |  |  | 9.49 |  |  |  | — |
Granted |  |  | 360,000 |  |  |  | 0.46 |  |  |  | 10.18 |  |  |  | — |
Vested |  |  | (137,565 | ) |  |  | 0.47 |  |  |  | 9.47 |  |  |  | — |
Expired |  |  | (776 | ) |  |  | 145.24 |  |  |  | — |  |  |  | — |
Forfeited |  |  | (53,447 | ) |  |  | 1.31 |  |  |  | — |  |  |  | — |
Unvested December 31, 2023 |  |  | 335,001 |  |  | $ | 1.83 |  |  |  | 10.70 |  |  |  | — |
Equity Incentive Plan 2009 [Member] |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |
Schedule of Vest Stock Option Activity |  | Information regarding the options approved by the Board of Directors under the Equity Plan of 2009 is summarized below. The plan expired on June 24, 2019: Schedule of Stock Option Activity
|  | 2023 |  |  | 2022 |
|  |  |  |  | Option |  |  | Weighted Average Exercise |  |  |  |  |  | Option |  |  | Weighted Average Exercise |
|  | Shares |  |  | Price |  |  | Price |  |  | Shares |  |  | Price |  |  | Price |
Outstanding, beginning of year |  |  | 124,399 |  |  |  | 13.20 – 1,003.20 |  |  |  | 22.23 |  |  |  | 128,504 |  |  |  | 13.20 – 2,127.84 |  |  |  | 25.58 |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeited |  |  | (5,047 | ) |  |  | 9.68-327.36 |  |  |  | 57.79 |  |  |  | (4,105 | ) |  |  | 16.76-2,127.84 |  |  |  | 129.88 |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Outstanding, end of year |  |  | 119,352 |  |  |  | 13.20-2,127.84 |  |  |  | 20.72 |  |  |  | 124,399 |  |  |  | 13.20-1,003.20 |  |  |  | 22.23 |
Exercisable, end of year |  |  | 119,352 |  |  |  | 13.20-2,127.84 |  |  |  |  |  |  |  | 124,399 |  |  |  | 13.20-1,003.20 |  |  |  |  |
Weighted average remaining contractual life (years) |  |  | 4.06 years |  |  |  |  |  |  |  |  |  |  |  | 5.98 years |  |  |  |  |  |  |  |  |
2018 Equity Incentive Plans [Member] |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |
Schedule of Vest Stock Option Activity |  | Information regarding the options approved by the Board of Directors under the Equity Plan of 2018 is summarized below: Schedule of Stock Option Activity
|  | 2023 |  |  | 2022 |
|  |  |  |  | Option |  |  | Weighted Average Exercise |  |  |  |  |  | Option |  |  | Weighted Average Exercise |
|  | Shares |  |  | Price |  |  | Price |  |  | Shares |  |  | Price |  |  | Price |
Outstanding, beginning of year |  |  | 2,474,971 |  |  |  | 0.31-9.68 |  |  |  | 1.72 |  |  |  | 1,650,017 |  |  |  | 1.11 – 9.68 |  |  |  | 2.35 |
Granted |  |  | 400,000 |  |  |  | 0.47-0.47 |  |  |  | 0.47 |  |  |  | 850,000 |  |  |  | 0.31 – 1.71 |  |  |  | 0.51 |
Forfeited |  |  | (60,829 | ) |  |  | 0.31-9.68 |  |  |  | 1.98 |  |  |  | (25,046 | ) |  |  | 1.85 – 9.68 |  |  |  | 1.86 |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Outstanding, end of year |  |  | 2,814,142 |  |  |  | 0.31-9.68 |  |  |  | 1.54 |  |  |  | 2,474,971 |  |  |  | 0.31 – 9.68 |  |  |  | 1.72 |
Exercisable, end of year |  |  | 2,397,474 |  |  |  | 0.31-327.36 |  |  |  | 4.71 |  |  |  | 1,916,637 |  |  |  | 0.41 – 9.68 |  |  |  | 2.22 |
Weighted average remaining contractual life (years) |  |  | 7.96 years |  |  |  |  |  |  |  |  |  |  |  | 9.65 years |  |  |  |  |  |  |  |  |
Available for future grants |  |  | 1,210,286 |  |  |  |  |  |  |  |  |  |  |  | 466,120 |  |  |  |  |  |  |  |  |

X
- Definition Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(8)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(7)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(7)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1 + Details
Name: | us-gaap_InvestmentIncomeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 360 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1 + Details
Name: | us-gaap_PropertyPlantAndEquipmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 35 -Paragraph 1D -Publisher FASB -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 35 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(01) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(02) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(03) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(01) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(02) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(03) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iv) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(v) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B + Details
Name: | us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=AIM_EquityIncentivePlanTwoThousandNineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=AIM_EquityIncentivePlansTwoThousandAndEighteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |